XML 33 R16.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
DERIVATIVE INSTRUMENTS
 12 Months Ended
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE INSTRUMENTS DERIVATIVE INSTRUMENTS
As of March 31, 2024, and 2023, the Company had no outstanding derivative contracts. The Company settled derivative contracts with notional values as follows:

Years Ended March 31,
202420232022
Designated Derivative Contracts
$179,528 $96,345 $110,430 
Non-Designated Derivative Contracts
— 31,044 38,659 
Total$179,528 $127,389 $149,089 
The following table summarizes the effect of Designated Derivative Contracts on unrealized gains or losses recorded in the consolidated statements of comprehensive income for changes in AOCL, net of tax:

Years Ended March 31,
202420232022
Gain recorded in OCI$4,090 $1,504 $4,161 
Reclassifications from AOCL into net sales(4,090)(1,504)(4,161)
Total$— $— $— 
Refer to Note 10, “Stockholders’ Equity,” for further information on the components of AOCL.

Subsequent to March 31, 2024, through May 9, 2024, the Company entered into no Non-Designated Derivative Contracts, but did enter into Designated Derivative Contracts with notional values totaling $27,759, which are expected to mature over the next 11 months. As of May 9, 2024, the Company’s outstanding hedging contracts were held by an aggregate of two counterparties.